![]() |
Volumn 8, Issue 7, 1999, Pages 1043-1062
|
Lercanidipine: A novel lipophilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity
|
Author keywords
Anti atherosclerotic; Calcium antagonists; Calcium channel blocker; Lercanidipine; Lipophilic; Vasoselective
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CALCIUM ANTAGONIST;
LERCANIDIPINE;
ABDOMINAL PAIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANKLE EDEMA;
ASTHENIA;
AUTONOMIC NERVOUS SYSTEM FUNCTION;
BINDING SITE;
CELL MEMBRANE;
CENTRAL NERVOUS SYSTEM FUNCTION;
CLINICAL TRIAL;
DIFFUSION;
DOSE TIME EFFECT RELATION;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG POTENCY;
FIRST PASS EFFECT;
FLUSHING;
GASTROINTESTINAL TRACT FUNCTION;
HEADACHE;
HEART MUSCLE CONTRACTILITY;
HEART PALPITATION;
HUMAN;
HYPERTENSION;
LIPID BILAYER;
LIPOPHILICITY;
META ANALYSIS;
NAUSEA;
NONHUMAN;
RESPIRATORY FUNCTION;
REVIEW;
TACHYCARDIA;
VERTIGO;
|
EID: 0032800311
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.7.1043 Document Type: Review |
Times cited : (51)
|
References (44)
|